Global Pulmonary Drug Delivery Devices Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report ID: GIR2201040434 | Category: Medical Devices & Consumables | Pages: 122 | Format: PDF | Published Date: October 06,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The Pulmonary Drug Delivery Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Pulmonary Drug Delivery Devices market size is estimated to be worth US$ 2917.7 million in 2021 and is forecast to a readjusted size of USD 3844.5 million by 2028 with a CAGR of 4.0% during review period. Asthma accounting for % of the Pulmonary Drug Delivery Devices global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Dry Powder Inhaler segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Pulmonary Drug Delivery Devices include Boehringer Ingelheim GmbH, Novartis AG, GlaxoSmithKline, AstraZeneca, and Teva Pharmaceutical Industries, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Pulmonary Drug Delivery Devices market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    Dry Powder Inhaler
    Metered Dose Inhaler
    Nebulizer
Market segment by Application can be divided into
    Asthma
    COPD
    Cystic Fibrosis
    Other
The key market players for global Pulmonary Drug Delivery Devices market are listed below:
    Boehringer Ingelheim GmbH
    Novartis AG
    GlaxoSmithKline
    AstraZeneca
    Teva Pharmaceutical Industries
    Merck
    MannKind
    Bristol-Myers Squibb
    Mylan N.V
    Omron Corp
    F. Hoffmann-La Roche
    3M Healthcare
    Sunovion Pharmaceuticals
    Koninklijke Philips N.V
    Gerresheimer AG
    Bespak
    AptarGroup
    SHL Group
    Nypro Healthcare
    Hovione
    Chiesi Farmaceutici S.P.A
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pulmonary Drug Delivery Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pulmonary Drug Delivery Devices, with price, sales, revenue and global market share of Pulmonary Drug Delivery Devices from 2019 to 2022.
Chapter 3, the Pulmonary Drug Delivery Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pulmonary Drug Delivery Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Pulmonary Drug Delivery Devices market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pulmonary Drug Delivery Devices.
Chapter 13, 14, and 15, to describe Pulmonary Drug Delivery Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Pulmonary Drug Delivery Devices Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Pulmonary Drug Delivery Devices Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Dry Powder Inhaler
        1.2.3 Metered Dose Inhaler
        1.2.4 Nebulizer
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Pulmonary Drug Delivery Devices Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Asthma
        1.3.3 COPD
        1.3.4 Cystic Fibrosis
        1.3.5 Other
    1.4 Global Pulmonary Drug Delivery Devices Market Size & Forecast
        1.4.1 Global Pulmonary Drug Delivery Devices Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Pulmonary Drug Delivery Devices Sales in Volume (2017-2028)
        1.4.3 Global Pulmonary Drug Delivery Devices Price (2017-2028) 
    1.5 Global Pulmonary Drug Delivery Devices Production Capacity Analysis
        1.5.1 Global Pulmonary Drug Delivery Devices Total Production Capacity (2017-2028)
        1.5.2 Global Pulmonary Drug Delivery Devices Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Pulmonary Drug Delivery Devices Market Drivers
        1.6.2 Pulmonary Drug Delivery Devices Market Restraints
        1.6.3 Pulmonary Drug Delivery Devices Trends Analysis
2 Manufacturers Profiles
    2.1 Boehringer Ingelheim GmbH
        2.1.1 Boehringer Ingelheim GmbH Details
        2.1.2 Boehringer Ingelheim GmbH Major Business
        2.1.3 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Product and Services
        2.1.4 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 Novartis AG
        2.2.1 Novartis AG Details
        2.2.2 Novartis AG Major Business
        2.2.3 Novartis AG Pulmonary Drug Delivery Devices Product and Services
        2.2.4 Novartis AG Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 GlaxoSmithKline
        2.3.1 GlaxoSmithKline Details
        2.3.2 GlaxoSmithKline Major Business
        2.3.3 GlaxoSmithKline Pulmonary Drug Delivery Devices Product and Services
        2.3.4 GlaxoSmithKline Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 AstraZeneca
        2.4.1 AstraZeneca Details
        2.4.2 AstraZeneca Major Business
        2.4.3 AstraZeneca Pulmonary Drug Delivery Devices Product and Services
        2.4.4 AstraZeneca Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Teva Pharmaceutical Industries
        2.5.1 Teva Pharmaceutical Industries Details
        2.5.2 Teva Pharmaceutical Industries Major Business
        2.5.3 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Product and Services
        2.5.4 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 Merck
        2.6.1 Merck Details
        2.6.2 Merck Major Business
        2.6.3 Merck Pulmonary Drug Delivery Devices Product and Services
        2.6.4 Merck Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 MannKind
        2.7.1 MannKind Details
        2.7.2 MannKind Major Business
        2.7.3 MannKind Pulmonary Drug Delivery Devices Product and Services
        2.7.4 MannKind Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 Bristol-Myers Squibb
        2.8.1 Bristol-Myers Squibb Details
        2.8.2 Bristol-Myers Squibb Major Business
        2.8.3 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Product and Services
        2.8.4 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 Mylan N.V
        2.9.1 Mylan N.V Details
        2.9.2 Mylan N.V Major Business
        2.9.3 Mylan N.V Pulmonary Drug Delivery Devices Product and Services
        2.9.4 Mylan N.V Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.10 Omron Corp
        2.10.1 Omron Corp Details
        2.10.2 Omron Corp Major Business
        2.10.3 Omron Corp Pulmonary Drug Delivery Devices Product and Services
        2.10.4 Omron Corp Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.11 F. Hoffmann-La Roche
        2.11.1 F. Hoffmann-La Roche Details
        2.11.2 F. Hoffmann-La Roche Major Business
        2.11.3 F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Product and Services
        2.11.4 F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.12 3M Healthcare
        2.12.1 3M Healthcare Details
        2.12.2 3M Healthcare Major Business
        2.12.3 3M Healthcare Pulmonary Drug Delivery Devices Product and Services
        2.12.4 3M Healthcare Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.13 Sunovion Pharmaceuticals
        2.13.1 Sunovion Pharmaceuticals Details
        2.13.2 Sunovion Pharmaceuticals Major Business
        2.13.3 Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Product and Services
        2.13.4 Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.14 Koninklijke Philips N.V
        2.14.1 Koninklijke Philips N.V Details
        2.14.2 Koninklijke Philips N.V Major Business
        2.14.3 Koninklijke Philips N.V Pulmonary Drug Delivery Devices Product and Services
        2.14.4 Koninklijke Philips N.V Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.15 Gerresheimer AG
        2.15.1 Gerresheimer AG Details
        2.15.2 Gerresheimer AG Major Business
        2.15.3 Gerresheimer AG Pulmonary Drug Delivery Devices Product and Services
        2.15.4 Gerresheimer AG Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.16 Bespak
        2.16.1 Bespak Details
        2.16.2 Bespak Major Business
        2.16.3 Bespak Pulmonary Drug Delivery Devices Product and Services
        2.16.4 Bespak Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.17 AptarGroup
        2.17.1 AptarGroup Details
        2.17.2 AptarGroup Major Business
        2.17.3 AptarGroup Pulmonary Drug Delivery Devices Product and Services
        2.17.4 AptarGroup Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.18 SHL Group
        2.18.1 SHL Group Details
        2.18.2 SHL Group Major Business
        2.18.3 SHL Group Pulmonary Drug Delivery Devices Product and Services
        2.18.4 SHL Group Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.19 Nypro Healthcare
        2.19.1 Nypro Healthcare Details
        2.19.2 Nypro Healthcare Major Business
        2.19.3 Nypro Healthcare Pulmonary Drug Delivery Devices Product and Services
        2.19.4 Nypro Healthcare Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.20 Hovione
        2.20.1 Hovione Details
        2.20.2 Hovione Major Business
        2.20.3 Hovione Pulmonary Drug Delivery Devices Product and Services
        2.20.4 Hovione Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.21 Chiesi Farmaceutici S.P.A
        2.21.1 Chiesi Farmaceutici S.P.A Details
        2.21.2 Chiesi Farmaceutici S.P.A Major Business
        2.21.3 Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Product and Services
        2.21.4 Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Pulmonary Drug Delivery Devices Breakdown Data by Manufacturer
    3.1 Global Pulmonary Drug Delivery Devices Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Pulmonary Drug Delivery Devices Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Pulmonary Drug Delivery Devices
    3.4 Market Concentration Rate
        3.4.1 Top 3 Pulmonary Drug Delivery Devices Manufacturer Market Share in 2021
        3.4.2 Top 6 Pulmonary Drug Delivery Devices Manufacturer Market Share in 2021
    3.5 Global Pulmonary Drug Delivery Devices Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Pulmonary Drug Delivery Devices Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions
4 Market Analysis by Region
    4.1 Global Pulmonary Drug Delivery Devices Market Size by Region
        4.1.1 Global Pulmonary Drug Delivery Devices Sales in Volume by Region (2017-2028)
        4.1.2 Global Pulmonary Drug Delivery Devices Revenue by Region (2017-2028)
    4.2 North America Pulmonary Drug Delivery Devices Revenue (2017-2028)
    4.3 Europe Pulmonary Drug Delivery Devices Revenue (2017-2028)
    4.4 Asia-Pacific Pulmonary Drug Delivery Devices Revenue (2017-2028)
    4.5 South America Pulmonary Drug Delivery Devices Revenue (2017-2028)
    4.6 Middle East and Africa Pulmonary Drug Delivery Devices Revenue (2017-2028)
5 Market Segment by Type
    5.1 Global Pulmonary Drug Delivery Devices Sales in Volume by Type (2017-2028)
    5.2 Global Pulmonary Drug Delivery Devices Revenue by Type (2017-2028)
    5.3 Global Pulmonary Drug Delivery Devices Price by Type (2017-2028)
6 Market Segment by Application
    6.1 Global Pulmonary Drug Delivery Devices Sales in Volume by Application (2017-2028)
    6.2 Global Pulmonary Drug Delivery Devices Revenue by Application (2017-2028)
    6.3 Global Pulmonary Drug Delivery Devices Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
    7.1 North America Pulmonary Drug Delivery Devices Sales by Type (2017-2028)
    7.2 North America Pulmonary Drug Delivery Devices Sales by Application (2017-2028)
    7.3 North America Pulmonary Drug Delivery Devices Market Size by Country
        7.3.1 North America Pulmonary Drug Delivery Devices Sales in Volume by Country (2017-2028)
        7.3.2 North America Pulmonary Drug Delivery Devices Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
    8.1 Europe Pulmonary Drug Delivery Devices Sales by Type (2017-2028)
    8.2 Europe Pulmonary Drug Delivery Devices Sales by Application (2017-2028)
    8.3 Europe Pulmonary Drug Delivery Devices Market Size by Country
        8.3.1 Europe Pulmonary Drug Delivery Devices Sales in Volume by Country (2017-2028)
        8.3.2 Europe Pulmonary Drug Delivery Devices Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Pulmonary Drug Delivery Devices Sales by Type (2017-2028)
    9.2 Asia-Pacific Pulmonary Drug Delivery Devices Sales by Application (2017-2028)
    9.3 Asia-Pacific Pulmonary Drug Delivery Devices Market Size by Region
        9.3.1 Asia-Pacific Pulmonary Drug Delivery Devices Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Pulmonary Drug Delivery Devices Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
    10.1 South America Pulmonary Drug Delivery Devices Sales by Type (2017-2028)
    10.2 South America Pulmonary Drug Delivery Devices Sales by Application (2017-2028)
    10.3 South America Pulmonary Drug Delivery Devices Market Size by Country
        10.3.1 South America Pulmonary Drug Delivery Devices Sales in Volume by Country (2017-2028)
        10.3.2 South America Pulmonary Drug Delivery Devices Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Pulmonary Drug Delivery Devices Sales by Type (2017-2028)
    11.2 Middle East & Africa Pulmonary Drug Delivery Devices Sales by Application (2017-2028)
    11.3 Middle East & Africa Pulmonary Drug Delivery Devices Market Size by Country
        11.3.1 Middle East & Africa Pulmonary Drug Delivery Devices Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Pulmonary Drug Delivery Devices Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
    12.1 Raw Material of Pulmonary Drug Delivery Devices and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Pulmonary Drug Delivery Devices
    12.3 Pulmonary Drug Delivery Devices Production Process
    12.4 Pulmonary Drug Delivery Devices Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Pulmonary Drug Delivery Devices Typical Distributors
    13.3 Pulmonary Drug Delivery Devices Typical Customers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Pulmonary Drug Delivery Devices Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?